A detailed history of Allianz Asset Management Gmb H transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 5,060 shares of CRL stock, worth $938,073. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,060
Previous 4,768 6.12%
Holding current value
$938,073
Previous $984,000 1.22%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$187.96 - $245.29 $54,884 - $71,624
292 Added 6.12%
5,060 $996,000
Q2 2024

Aug 13, 2024

BUY
$206.39 - $268.73 $134,979 - $175,749
654 Added 15.9%
4,768 $984,000
Q1 2024

May 13, 2024

BUY
$203.52 - $273.43 $68,789 - $92,419
338 Added 8.95%
4,114 $1.11 Million
Q4 2023

Feb 12, 2024

SELL
$164.52 - $238.84 $320,155 - $464,782
-1,946 Reduced 34.01%
3,776 $892,000
Q3 2023

Nov 13, 2023

BUY
$194.44 - $217.61 $176,551 - $197,589
908 Added 18.86%
5,722 $1.12 Million
Q2 2023

Aug 11, 2023

SELL
$183.71 - $210.25 $2.69 Million - $3.08 Million
-14,629 Reduced 75.24%
4,814 $1.01 Million
Q1 2023

May 11, 2023

BUY
$191.89 - $259.92 $3.73 Million - $5.05 Million
19,443 New
19,443 $3.92 Million
Q4 2021

Feb 11, 2022

SELL
$351.38 - $448.68 $11.1 Million - $14.2 Million
-31,588 Reduced 58.0%
22,870 $8.62 Million
Q3 2021

Nov 10, 2021

BUY
$372.64 - $458.3 $8.17 Million - $10 Million
21,923 Added 67.38%
54,458 $22.5 Million
Q2 2021

Aug 16, 2021

BUY
$294.17 - $371.65 $50,891 - $64,295
173 Added 0.53%
32,535 $12 Million
Q1 2021

May 13, 2021

BUY
$249.67 - $299.48 $4.77 Million - $5.72 Million
19,099 Added 144.0%
32,362 $9.38 Million
Q4 2020

Feb 16, 2021

SELL
$222.0 - $252.62 $3.25 Million - $3.69 Million
-14,618 Reduced 52.43%
13,263 $3.31 Million
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $506,666 - $653,534
-2,886 Reduced 9.38%
27,881 $6.31 Million
Q2 2020

Aug 14, 2020

SELL
$118.84 - $189.72 $1.87 Million - $2.98 Million
-15,711 Reduced 33.8%
30,767 $5.36 Million
Q1 2020

May 14, 2020

SELL
$98.9 - $178.34 $2.53 Million - $4.56 Million
-25,550 Reduced 35.47%
46,478 $5.87 Million
Q4 2019

Feb 13, 2020

SELL
$126.05 - $152.76 $13.9 Million - $16.8 Million
-110,281 Reduced 60.49%
72,028 $11 Million
Q3 2019

Nov 13, 2019

SELL
$125.07 - $143.67 $7.35 Million - $8.44 Million
-58,774 Reduced 24.38%
182,309 $24.1 Million
Q2 2019

Aug 08, 2019

BUY
$123.4 - $148.55 $792,845 - $954,433
6,425 Added 2.74%
241,083 $34.2 Million
Q1 2019

May 13, 2019

BUY
$104.82 - $146.73 $6.05 Million - $8.47 Million
57,714 Added 32.62%
234,658 $34.1 Million
Q4 2018

Feb 14, 2019

SELL
$105.09 - $137.23 $2.68 Million - $3.5 Million
-25,540 Reduced 12.61%
176,944 $20 Million
Q3 2018

Nov 13, 2018

SELL
$112.11 - $134.54 $1.32 Million - $1.58 Million
-11,751 Reduced 5.49%
202,484 $27.2 Million
Q2 2018

Aug 13, 2018

SELL
$102.37 - $117.25 $2.6 Million - $2.98 Million
-25,411 Reduced 10.6%
214,235 $24.1 Million
Q1 2018

May 14, 2018

BUY
$98.19 - $115.2 $2.51 Million - $2.95 Million
25,571 Added 11.94%
239,646 $25.6 Million
Q4 2017

Feb 13, 2018

BUY
$100.43 - $118.09 $2.61 Million - $3.07 Million
25,976 Added 13.81%
214,075 $23.4 Million
Q3 2017

Nov 13, 2017

SELL
$96.72 - $109.26 $7.67 Million - $8.67 Million
-79,318 Reduced 29.66%
188,099 $20.3 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-16,555 Reduced 5.83%
267,417 $27.1 Million
Q1 2017

Apr 17, 2019

SELL
N/A
-27,703 Reduced 8.89%
283,972 $25.5 Million
Q4 2016

Apr 17, 2019

BUY
N/A
243,760 Added 358.92%
311,675 $23.7 Million
Q3 2016

Apr 17, 2019

BUY
N/A
67,915
67,915 $5.65 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.43B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.